Novartis Pharmaceuticals Canada Inc. ("Novartis Canada") announced today that Health Canada has granted approval for VANRAFIATM (atrasentan tablets) for proteinuria reduction in adults with primary ...
Novartis is executing more layoffs at its U.S. headquarters in East Hanover, New Jersey, handing 322 employees pink slips.
Novartis boasts a 26% net margin and a fortress balance sheet, while Teva's turnaround has returned it to profitability, but ...
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.
Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...
Novartis has started to feel the squeeze from generics to its top-selling drug, heart therapy Entresto. The erosion was obvious. After MSN Pharmaceuticals opened the floodgates to Entresto generics in ...
Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with Novartis to advance the discovery of therapeutic antibodies using artificial ...
Novartis is a large drugmaker with a wide-ranging portfolio. Like all drugmakers, it faces the challenge of patent expirations. Still, the company's pipeline looks likely to support ongoing growth. 10 ...
Adds potential first-in-class, N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...
A warehouse fire at an 80-year-old Michigan craft supply company triggered 179 remote worker layoffs in New Jersey — one of ...
Pharmaceutical Technology on MSN

Novartis to acquire Myricx Bio in up to $1.5bn deal

The acquisition is expected to close in the second half of 2026, pending customary closing conditions and regulatory ...
With the latest layoffs, Novartis expects to let go of around 800 employees by the end of 2028. More than half of the cuts ...